PUBLISHER: QYResearch | PRODUCT CODE: 1859920
PUBLISHER: QYResearch | PRODUCT CODE: 1859920
The global market for Metformin Hydrochloride was estimated to be worth US$ 391 million in 2024 and is forecast to a readjusted size of US$ 584 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Metformin Hydrochloride cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5*HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.In 2024, global Metformin Hydrochloride reached approximately 66400 MT, with an average global market price of around US$ 5894 per MT.
Metformin Hydrochloride is a widely used oral antihyperglycemic drug, primarily prescribed for the treatment of type 2 diabetes. It belongs to the biguanide class and works by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity in peripheral tissues. Its well-established efficacy, safety profile, and low cost have made it the first-line therapy for millions of patients worldwide. The global market is highly standardized, with a production capacity of about 120,000 tons, a relatively thin gross profit margin of 6%-20%, and single-line production capacities commonly in the range of 3,000-5,000 tons, reflecting a mature, large-scale pharmaceutical intermediate market.
The industry chain begins upstream with raw materials such as dimethylamine hydrochloride and dicyandiamide, which undergo chemical synthesis to produce metformin base. This intermediate is further crystallized and refined with hydrochloric acid to yield metformin hydrochloride in pharmaceutical-grade quality. Midstream, manufacturers formulate the active pharmaceutical ingredient (API) into bulk drug products or supply it to formulation companies. Downstream, the demand is dominated by generic drug manufacturers producing tablets, extended-release formulations, and fixed-dose combinations with other antidiabetic drugs. The industry structure is characterized by significant competition among bulk producers, especially in China and India, which supply the majority of global API demand.
Key market drivers include the growing global prevalence of type 2 diabetes, driven by aging populations, sedentary lifestyles, and dietary changes, particularly in developing countries. Increasing healthcare access in emerging economies continues to expand the patient base for metformin-based therapies. Moreover, the widespread acceptance of metformin as the cornerstone of diabetes management by international guidelines ensures consistent demand. Additional drivers include its applications beyond diabetes, such as polycystic ovary syndrome (PCOS) treatment and research into potential uses in aging-related conditions and oncology, which further broaden its clinical relevance. Despite competitive pricing pressure and low margins, its indispensable role in diabetes care secures long-term market stability.
This report aims to provide a comprehensive presentation of the global market for Metformin Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metformin Hydrochloride by region & country, by Type, and by Application.
The Metformin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Hydrochloride.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metformin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metformin Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.